期刊
NANOMEDICINE
卷 6, 期 8, 页码 1413-1428出版社
FUTURE MEDICINE LTD
DOI: 10.2217/NNM.11.122
关键词
anti-TB drugs; liposomes; macrophages; nanomedicine; targeting
资金
- FCT (Lisbon) [SFRH/BD/63318/2009]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/63318/2009] Funding Source: FCT
TB is an infectious disease that is far from being eradicated and controlled. The treatment for TB is associated with noncompliance to therapy because it consists of a long-term treatment with a multidrug combination and is associated with the appearance of several side effects. Liposomal formulations are being developed with first- and second-line antibiotics, and might be an extremely useful alternative to current therapies. This article will thus focus on the role of liposomes as nanodelivery systems for the treatment of TB. Among several advantages, these nanocarriers allow an increase in the bioavailability of antibiotics, which may lead to a reduction in the time of treatment. Results obtained with such nanosystems, although preliminary, are promising and are perspective of the use of inhalation for TB treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据